NASDAQ NMS - GLOBAL MARKET · CYRX
+0.00% · +$0.0000 · Vol Not reported
Market closed · last close shown
Cryoport Inc

Cryoport Inc

Life Sciences Tools & Services
$15.49

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS
REFRESHES DAILY
AI Analysis
Sovereign

Why is CYRX moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Cryoport Inc
PHARMACEUTICAL PREPARATIONS
Listed since
1993
Employees
738
Country
US

CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$15.49
Last session
Day high
$15.49
Last session
Day low
$15.49
Last session
Previous close
$15.49
52W high
$16.28
-4.85% from high
52W low
$14.46
57% of range
Market cap
$780.7M
P/E
11.56×
EPS
$1.34
Shares out
50.4M
VWAP
$15.49
Last session
Price history computed in-house
1W
-3.19%
SMA 50 $15.25 · above
SMA 200 $15.25 · above
52W position 57%
Veridion warehouse edge

Warehouse intelligence for CYRX.

Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Statements refresh in progress
SEC Form 4 ledger

CYRX insider activity

Cryoport Inc

Score
Coverage building
Pressure
Net selling
Filings
31
Buys / sells
14 / 17
Net value
-$3.2M
Insiders
6
Named filers
ZJ
ZECCHINI EDWARD J
Insider
Leadership
MR
Mandalam Ramkumar
Insider
Leadership
SR
STEFANOVICH ROBERT
Insider
Leadership
Cluster

2 insiders bought in the last 90 days

Net pressure

Net selling: -$3.2M across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Filing dateTrade dateInsiderTitleTypePriceQtyOwnedValueReceipt
2026-06-122026-06-11ZECCHINI EDWARD JInsidersell$14.4733,600109,719$486KSEC Form 4
2026-06-122026-06-11ZECCHINI EDWARD JInsiderbuy$4.8033,600143,319$161KSEC Form 4
2026-06-122026-06-10ZECCHINI EDWARD JInsidersell$15.231,400109,719$21KSEC Form 4
2026-06-122026-06-10ZECCHINI EDWARD JInsiderbuy$4.801,400111,119$7KSEC Form 4
2026-06-082026-06-08Mandalam RamkumarInsidersell$15.4423,21467,894$358KSEC Form 4
Full Form 4 history requires Sovereign

Showing 5 recent rows. Sovereign unlocks 26 additional rows, full sorting, and the named-filer history.

Upgrade to Sovereign · $25/mo
Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Congress filing snapshot refresh in progress
Federal contracts

CYRX contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for CYRX in this window.
Lobbying spend

CYRX lobbying filings, year to date.

Registered lobbying filings matched to Cryoport Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for CYRX in this window.
Latest news · CYRX
Refresh interval: 5 minutes · Source: Market news insights
News snapshot refresh in progress
Analyst ratings
Sovereign unlock shows live analyst consensus for CYRX.
Options
Sovereign unlock shows live options positioning for CYRX.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.